128 related articles for article (PubMed ID: 35367789)
1. In vivo imaging of microenvironmental and anti-PD-L1-mediated dynamics in cancer using S100A8/S100A9 as an imaging biomarker.
Helfen A; Rieß J; Fehler O; Stölting M; An Z; Kocman V; Schnepel A; Geyer C; Gerwing M; Masthoff M; Vogl T; Höltke C; Roth J; Ng T; Wildgruber M; Eisenblätter M
Neoplasia; 2022 Jun; 28():100792. PubMed ID: 35367789
[TBL] [Abstract][Full Text] [Related]
2. Target-Specific Imaging of Cathepsin and S100A8/A9 Reflects Specific Features of Malignancy and Enables Estimation of Tumor Malignancy.
Helfen A; Große Hokamp N; Geyer C; Heindel W; Bremer C; Vogl T; Höltke C; Masthoff M; Barczyk-Kahlert K; Roth J; Wildgruber M; Eisenblaetter M
Mol Imaging Biol; 2020 Feb; 22(1):66-72. PubMed ID: 31098983
[TBL] [Abstract][Full Text] [Related]
3. Intracellular expression of inflammatory proteins S100A8 and S100A9 leads to epithelial-mesenchymal transition and attenuated aggressivity of breast cancer cells.
Cormier K; Harquail J; Ouellette RJ; Tessier PA; Guerrette R; Robichaud GA
Anticancer Agents Med Chem; 2014 Jan; 14(1):35-45. PubMed ID: 24041228
[TBL] [Abstract][Full Text] [Related]
4. Optical in vivo imaging of the alarmin S100A9 in tumor lesions allows for estimation of the individual malignant potential by evaluation of tumor-host cell interaction.
Becker A; Große Hokamp N; Zenker S; Flores-Borja F; Barzcyk K; Varga G; Roth J; Geyer C; Heindel W; Bremer C; Vogl T; Eisenblaetter M
J Nucl Med; 2015 Mar; 56(3):450-6. PubMed ID: 25678492
[TBL] [Abstract][Full Text] [Related]
5. S100A9-Imaging Enables Estimation of Early Therapy-Mediated Changes in the Inflammatory Tumor Microenvironment.
Helfen A; Schnepel A; Rieß J; Stölting M; Gerwing M; Masthoff M; Vogl T; Roth J; Höltke C; Wildgruber M; Eisenblätter M
Biomedicines; 2021 Jan; 9(1):. PubMed ID: 33401528
[TBL] [Abstract][Full Text] [Related]
6. S100A8 and S100A9 in Cancer.
Chen Y; Ouyang Y; Li Z; Wang X; Ma J
Biochim Biophys Acta Rev Cancer; 2023 May; 1878(3):188891. PubMed ID: 37001615
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 17 Promotes Expression of Alarmins S100A8 and S100A9 During the Inflammatory Response of Keratinocytes.
Christmann C; Zenker S; Martens L; Hübner J; Loser K; Vogl T; Roth J
Front Immunol; 2020; 11():599947. PubMed ID: 33643287
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis of the complex formation between the two calcium-binding proteins S100A8 (MRP8) and S100A9 (MRP14).
Leukert N; Sorg C; Roth J
Biol Chem; 2005 May; 386(5):429-34. PubMed ID: 15927886
[TBL] [Abstract][Full Text] [Related]
9. Identification of S100A8 and S100A9 as negative regulators for lymph node metastasis of gastric adenocarcinoma.
Choi JH; Shin NR; Moon HJ; Kwon CH; Kim GH; Song GA; Jeon TY; Kim DH; Kim DH; Park DY
Histol Histopathol; 2012 Nov; 27(11):1439-48. PubMed ID: 23018243
[TBL] [Abstract][Full Text] [Related]
10. Visualization of Tumor-Immune Interaction - Target-Specific Imaging of S100A8/A9 Reveals Pre-Metastatic Niche Establishment.
Eisenblaetter M; Flores-Borja F; Lee JJ; Wefers C; Smith H; Hueting R; Cooper MS; Blower PJ; Patel D; Rodriguez-Justo M; Milewicz H; Vogl T; Roth J; Tutt A; Schaeffter T; Ng T
Theranostics; 2017; 7(9):2392-2401. PubMed ID: 28744322
[No Abstract] [Full Text] [Related]
11. S100A8/A9 in Inflammation.
Wang S; Song R; Wang Z; Jing Z; Wang S; Ma J
Front Immunol; 2018; 9():1298. PubMed ID: 29942307
[TBL] [Abstract][Full Text] [Related]
12. Tumor-infiltrating monocytes/macrophages promote tumor invasion and migration by upregulating S100A8 and S100A9 expression in cancer cells.
Lim SY; Yuzhalin AE; Gordon-Weeks AN; Muschel RJ
Oncogene; 2016 Nov; 35(44):5735-5745. PubMed ID: 27086923
[TBL] [Abstract][Full Text] [Related]
13. S100A8 and S100A9 overexpression is associated with poor pathological parameters in invasive ductal carcinoma of the breast.
Arai K; Takano S; Teratani T; Ito Y; Yamada T; Nozawa R
Curr Cancer Drug Targets; 2008 Jun; 8(4):243-52. PubMed ID: 18537548
[TBL] [Abstract][Full Text] [Related]
14. S100A9 induces differentiation of acute myeloid leukemia cells through TLR4.
Laouedj M; Tardif MR; Gil L; Raquil MA; Lachhab A; Pelletier M; Tessier PA; Barabé F
Blood; 2017 Apr; 129(14):1980-1990. PubMed ID: 28137827
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of calcium-binding protein S100A8 and S100A9 expression in non-small cell lung cancer.
Huang H; Huang Q; Tang T; Gu L; Du J; Li Z; Lu X; Zhou X
Thorac Cancer; 2018 Jul; 9(7):800-804. PubMed ID: 29733516
[TBL] [Abstract][Full Text] [Related]
16. Deficiency of S100A8/A9 attenuates pulmonary microvascular leakage in septic mice.
Yu J; Zhao B; Pi Q; Zhou G; Cheng Z; Qu C; Wang X; Kong L; Luo S; Du D; Guo Y
Respir Res; 2023 Nov; 24(1):288. PubMed ID: 37978525
[TBL] [Abstract][Full Text] [Related]
17. S100A8/A9 mRNA induction in an ex vivo model of endotoxin tolerance: roles of IL-10 and IFNγ.
Fontaine M; Planel S; Peronnet E; Turrel-Davin F; Piriou V; Pachot A; Monneret G; Lepape A; Venet F
PLoS One; 2014; 9(6):e100909. PubMed ID: 24956170
[TBL] [Abstract][Full Text] [Related]
18. Pathogenic Role of the Damage-Associated Molecular Patterns S100A8 and S100A9 in Coxsackievirus B3-Induced Myocarditis.
Müller I; Vogl T; Pappritz K; Miteva K; Savvatis K; Rohde D; Most P; Lassner D; Pieske B; Kühl U; Van Linthout S; Tschöpe C
Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29158436
[TBL] [Abstract][Full Text] [Related]
19. Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies.
Wagner NB; Weide B; Gries M; Reith M; Tarnanidis K; Schuermans V; Kemper C; Kehrel C; Funder A; Lichtenberger R; Sucker A; Herpel E; Holland-Letz T; Schadendorf D; Garbe C; Umansky V; Utikal J; Gebhardt C
J Immunother Cancer; 2019 Dec; 7(1):343. PubMed ID: 31806053
[TBL] [Abstract][Full Text] [Related]
20. The antimicrobial heterodimer S100A8/S100A9 (calprotectin) is upregulated by bacterial flagellin in human epidermal keratinocytes.
Abtin A; Eckhart L; Gläser R; Gmeiner R; Mildner M; Tschachler E
J Invest Dermatol; 2010 Oct; 130(10):2423-30. PubMed ID: 20555353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
